Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) ("60 Degrees" or the "Company"), a pharmaceutical company focused on developing new medicines for vector-borne disease, today announced that three ...
For many families in Asia, Latin America and the Pacific, malaria is not a one-time illness. Plasmodium vivax, one of the five parasites that cause malaria in humans, has a troubling habit of ...
A new evidence-based viewpoint published in The Lancet Regional Health: Southeast Asia has raised concerns about the reliability of the widely used glycated hemoglobin (HbA1c) test for diagnosing and ...
WASHINGTON, Jan. 22, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) ("60 Degrees Pharma" or the "Company"), a pharmaceutical company focused on developing new ...
A 32-year-old woman of African descent presented to the emergency department with a 2-day history of fatigue, yellowish skin discolouration, and passing dark-coloured urine. Initially, treating ...
6-month commercial pilot demonstrated increasing demand among prescribers Expansion plan includes doubling the number of sales reps, a new GoodRx partnership, and enhanced digital marketing campaign ...
The declining efficacy and widespread resistance to antimalarial drugs (AMD) pose significant challenges to global malaria control and elimination efforts. To enhance treatment efficacy, the World ...
New 8-count bottles now available through major retail pharmacies ARAKODA® is the only weekly prophylactic therapy to provide protection against the blood and liver stages of malaria WASHINGTON, June ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results